309 results about "Allergic dermatitis" patented technology

The invention discloses a Prinsepia utilis Royle oil-containing functional skin care product and a preparation method thereof. The Prinsepia utilis Royle oil-containing functional skin care product is prepared from the following raw materials in part by weight: 1 to 2 parts of Prinsepia utilis Royle oil, 10 to 25 parts of purslane extracting solution, 5 parts of glycerol, 2 to 3 parts of 1,2-pentanediol, 5 to 7 parts of caprylic/caprictriglycerides, 2 parts of synthetic squalane, 1 to 5 parts of tocopheryl acetate, 1 to 3 parts of cetearyl alcohol, 0.1 to 0.2 part of allantoin, 0.6 to 0.9 part of coconut oil-base glucoside, 0.5 to 1 part of coconut oil alcohol, 0.5 to 2 parts of glyceryl stearate, 0.1 to 1 part of sodium hyaluronate and the balance of water. The functional skin care product has mild property and high safety without toxic or side reaction and anaphylactic reaction, can repair the destructed skin barrier, resists inflammation and skin ageing, and has a good effect and high safety of assisting in treating skin diseases related with skin barrier destruction, such as facial dermatitis (hormone dependence dermatitis, allergic dermatitis and acne), atopic dermatitis and the like.

The invention discloses an external preparation for skin. The preparation comprises components including a pseudo-ceramide compound, a steroid, fatty acid and N-acylethanolamine and contains no grease. Through the manner, the preparation can be used for skin care and maintenance as well as treatment of some skin symptoms, particularly dermatitis symptoms such as atopic dermatitis, eczema, acne, seborrhoeic dermatitis, contact dermatitis, allergic dermatitis, solar dermatitis and the like, particularly in areas where sebaceous glands are abundant, such as faces, scalp, necks, chests, backs and buttocks.

The invention relates to an anti-sensitization and restoration external preparation for skin, belonging to the technical field of Chinese medicinal preparations. Based on the research and treatment principle of the pathogenic mechanism of skin impairment aggravation of a patient caused by sensitive or allergic dermatitis and hormone therapy sensitive or allergic dermatitis according to the traditional Chinese medicine and in combination with other component raw materials, active ingredients contained in the preparation have the effects of clearing away heat and toxic materials, resisting sensitization, restoring, converging and increasing skin elasticity and luster. The preparation can be prepared into cream or water aqua. The anti-sensitization and restoration external preparation is directly applied to the infection focuses of the patient, has no toxic or side effect, has a good curative effect, is easy to use, and is suitable for the patient suffering from skin impairment caused bysensitive or allergic dermatitis and hormone therapy sensitive or allergic dermatitis; and the problems of larger skin impairment of the patient caused by the conventional hormone therapy of sensitive or allergic dermatitis, difficulty in treating and poor curative effect are solved.

The present invention relates to a novel compound or a salt thereof, which is useful as a CRTH2 antagonist, especially as a medicament for disorder that participates eosinophil, for example, allergic disorder such as asthma, allergic rhinitis, allergic dermatitis, conjunctival inflammation, hives, eosinophilic bronchitis, food allergy, inflammation of the nasal sinuses, multiple sclerosis, angiitis, or chronic obstructive pulmonary disease (COPD) and the like.

The invention relates to the technical field of antibodies, and especially relates to a human thymus stromal lymphopoietin monoclonal antibody and an application thereof. The TSLP antibody can be specifically combined with hTSLP, has high affinity, and can effectively inhibit the combination of TSLP and a receptor thereof so as to inhibit activation of a downstream signal path and activation of immune cells by TSLP. The TSLP antibody has great significance in detection of the content of hTSLP and allergic asthma, and diagnosis, treatment and prognosis of inflammatory or allergic inflammatory diseases such as chronic obstructive pulmonary disease, allergic dermatitis, allergic rhinitis, allergic nasosinusitis, eosinophilic granulocytic esophagitis, allergic conjunctivitis, inflammatory bowel disease or atopic dermatitis.

An inflammation-relieving Chinese medicine for treating allergic rhinitis, allergic dermatitis, nasal polyp, pyogenic tympanitis, pyogenic skin infection, etc is prepared from streptomycin, chloromycetin, hydrocortisone, and 6 Chinese-medicinal materials including astragalus root, cotis root, honeysuckle flower, etc.

An application of the extract of pithecellobium clypearia benth/archidendron clypearia Jack. Nielsen in preparing food, cosmetics and medicines for treating allergic dermatitis, allergic rhinitis, allergic pharyngitis, pollen anaphylaxis and other allergic diseases is disclosed.

The invention relates to a medicament for treating and resisting allergic diseases, which is prepared by combining vegetables, honey, red dates, ginger, salt and Chinese medicinal herbs together and particularly suitable for people with allergic dermatitis, allergic rhinitis, allergic pharyngitis and allergic cough and asthma. The combined medicament for resisting the allergic diseases is prepared from the following materials: 10-20g of ginger, 20-40g of red date, 40-60g of honey and the balance of Chinese medicinal herbs, wherein the Chinese medicinal herbs comprise the following components: 5-12g of honeysuckle, 5-12g of weeping forsythia, 5-10g of chrysanthemum, 5-12g of bamboo leaf, 3-8g of great burdock achene, 5-12g of platycodon root, 3-6g of mint, 2-5g of biond magnolia flower, 3-8g of wrinkled gianthyssop herb, 4-9 of lumbricus, 5-10g of smoked plum, 5-10g of common peony root, 4-9g of szechuan lovage rhizome, 4-9g of red flower, 8-12g of magnolia flower, 5-10g of angelica sinensis tail, 5-10g of red-rooted salvia root, 10-15g of radix curcumae, 10-15g of peach kernel, 1-3g of manchurian wildginger, 5-12g of cocklebur fruit and 10g of willowleaf swallowwort rhizome.

The invention relates to a Chinese medicine for treating allergic dermatitis. The Chinese medicine is prepared from the following medicinal materials in parts by weight: 15-30 parts of astragalus, 10-15 parts of divaricate saposhnikovia root, 10-15 parts of paniculate swallowwort root, 8-12 parts of fried large-head atractylodes rhizome, 10-15 parts of fineleaf schizonepeta herb, 8-12 parts of lightyellow sophora root, 15-20 parts of pearl barley, 10-15 parts of cicada shell, 10-15 parts of mint, 10-15 parts of baikal skullcap root, 8-12 parts of Chinese angelica, 10-15 parts of bunge corydalis herb, 10-15 parts of dandelion and 6-9 parts of liquoric root. As proved by a clinical experiment, the Chinese medicine can be used for treating allergic dermatitis safely and effectively.

The embodiment of the invention provides a collagen dressing plaster and a preparing method and application thereof, and relates to the field of medicine and health. The collagen dressing plaster is used for treating and caring acne, facial allergic dermatitis, facial burns and scalds and other wound surfaces. The preparing method includes the steps that a collagen solution containing macromolecular collagen and micromolecular collagen is fully dissolved in a diluted acid solution with the mass concentration of 0.05-0.1% to obtain a collagen solution; a small amount of medical preservative solution is added into the collagen solution; a sterile aluminum foil bag is filled with the collagen solution, sealed and packaged to obtain the collagen dressing plaster, and a matrix used for the collagen solution to adhere to is put in the sterile aluminum foil bag. The collagen dressing plaster is used for postoperative repair and caring after facial laser and photon treatment to have the effects of promoting wound healing and rebuilding and recovering skin barrier functions.

The invention relates to an external medicament composition for treating skin diseases, which is characterized in that the composition is prepared from the following raw materials in weight portion: 50 to 300 portions of Chinese mugwort leaves, 10 to 60 portions of mint, 10 to 80 portions of dittany bark, 10 to 60 portions of radix salviae miltiorrhizae, 10 to 60 portions of radix scutellariae and 10 to 50 portions of herba schizonepetae. The preparation method adopts the prior traditional Chinese medicine preparation technique, and the external medicament composition can be prepared into external location, liniment, ointment, spraying agent, and the like suitable to be used clinically. In the invention, the traditional Chinese medicine has the efficacies of clearing away heat and expelling the wind, removing dampness to relieve itching, reducing tumescence, and the like, and is suitable for symptoms such as pruritus caused by allergic skin diseases such as hives and the like, and allergic dermatitis, neurodermitis, and the like. Through clinical observation, the external medicament composition has the advantages of short treatment time, quick symptom relieving, good curative effect, safety, no toxic and side effects, and no irritation to skin.

The invention provides a probiotics and prebiotics compound preparation and a processing method thereof. The processing method comprises the following processing steps: (1) disinfecting hands of people, equipment and tools with 72 percent alcohol before production; (2) drying stachyose, fructooligosaccharide, galactooligosaccharide, isomalto-oligosaccharide, lactobacillus rhamnosus HN001 and bifidobacterium lactis respectively; (3) mixing 25 to 35 parts of the stachyose, 15 to 25 parts of the fructooligosaccharide, 35 to 45 parts of the galactooligosaccharide, 5 to 15 parts of the isomalto-oligosaccharide and 0.05 to 0.1 part of caffeine; (4) carrying out pasteurization on mixed saccharides; (5) adding the lactobacillus rhamnosus HN001 and the bifidobacterium lactis Bi-07 into the mixed saccharides according to the ratio of 3*10<8>CFU/g. The compound preparation prepared by the method can be used for effectively completing intestinal flora so that the burdens of allergic dermatitis are alleviated.

The invention provides an artemisia pollen allergen vaccine, and a preparation method and application thereof. The artemisia pollen allergen vaccine comprises an artemisia sieversiana pollen allergen, an artemisia annua pollen allergen and an artemisia argyi pollen allergen. Compared with a single artemisia pollen allergen vaccine, the combined vaccine has the advantages that the effectiveness of treatment is improved while the safety can be ensured; and the artemisia pollen allergen vaccine can be used for treating allergic dermatitis, chronic urticaria, allergic rhinitis and allergic asthma which are caused by allergy to multiple artemisia pollens.

The invention discloses a sonchus plant extract used for curing skin diseases and application thereof in preparing medicament for treating skin diseases; the extract is obtained by taking sonchus plants as raw material, extracting by water, filtering and sterilizing the filtrate at high temperature. For water extracting, the temperature is 80-100 DEG C, the period is 1-5 hours, and the extract is filtered with a non-metal filter screen of 200-1,000 meshes. Both the extract of sonchus common sow thistle and the extract of sonchus brachyotus have the functions of antimycotic, antianaphylaxis, antiphlogosis, itch relieving and the like. The extract can be used for curing allergic dermatitis, eczema, skin itch, pimple, scar itch, dermatitis caused by mosquito bite, mycotic infection and other skin diseases. The effective rate and the cure ratio for curing allergic dermatitis, eczema, skin itch, pimple, scar itch, and dermatitis caused by mosquito bite are both 100%, the effective rate for curing dermatophytosis cuased by mycotic is 100% and the cure ration therefor is 70-75%.

It is an object to provide an antiviral agent that can be used for persons having sensitive skin or on the face, inactivates viruses such as a norovirus and an influenza virus, and is excellent in germicidal properties. Further provided is a cleansing agent that does not lead to environmental pollution since the cleansing agent is easily decomposed in the natural environment, scarcely causes eczema and allergic dermatitis since no germicidal agent is added, and has an antiviral performance. The antiviral agent containing a surface-active agent having a C18 unsaturated alkyl group as an active component. It is not always necessary to lather or rinse off with water like cleansing agents such as medicated soaps since the antiviral agent of the present invention at a very low concentration can inactivate the virus.

The invention discloses a traditional medicinal composition for treating skin diseases, which is prepared from Chinese herbs including peach kernels, flavescent sophora root, cnidium fruit, boneol and peppermint through the conventional processes.

The invention relates to a compound of sophocarpidine and glycyrrhetinic acid double salt, a compound of oxymatrine glycyrrhetinic acid double salt, and a composition, a preparation method and use thereof, and particularly relates to the use of two double salts in the treatment of inflammation, bacterial infected skin diseases and allergic dermatitis. The polarity of the glycyrrhetinic acid, easy oxidation of sophocarpidine, and strong moisture adsorption of oxymatrine are well improved by the sophocarpidine glycyrrhetinic acid double salt; the preparation method is simple and easy to operate, and is high in yield; meanwhile, a good synergistic effect is displayed in anti-inflammation and antibiosis; and the dosage is obviously reduced.

The invention relates to the technical field of biology and discloses a colonization probiotic preparation and application and medicines thereof. The colonization probiotic preparation is used for directly acting on the respiratory mucosa and comprises a surfactant and probiotics. By the surfactant, modification of a sol layer and a gel layer of respiratory tract mucus is realized, probability and speed in contact of the probiotics with respiratory mucosa cells are increased, cell surface hydrophobicity of the probiotics is changed, an adhesion rate of the probiotics and respiratory mucosa epithelial cells is increased, and accordingly the technical bottleneck of difficulty in colonization of the probiotics to the respiratory mucosa under expelling action of a mucociliary transmission system is solved. The colonization probiotic preparation can be applied to fields of preparation of medicines for treatment of rhinitis, treatment of asthma, treatment of allergic dermatitis or treatment of cranial nerve diseases, anti-nasopharynx-cancer, anti-lung-cancer or anti-cold medicines or medicines for prevention or treatment of respiratory infectious diseases.

The invention relates to paeonol niosome emulsifiable paste. The paste is prepared by the following steps: paeonol, a nonionic surfactant, cholesterol and the like are used for preparing a niosome suspension by a self assembly mode; the suspension, paraffin, glyceryl monostearate, vaseline, propylene glycol, ethyl p-hydroxybenzoate and other auxiliary materials are used for preparing a niosome emulsion; the paste can be partially applied to skin, and can treat allergic dermatitis and eczema with skin whitening effects. The prepared niosomes have round forms, uniform particle size distribution, and high encapsulation efficiency. The paeonol niosome emulsifiable paste has good uniformity and stable properties, and in vitro rat and mouse skin experiment results prove that intracutaneous retention volume of medicaments is substantially increased with slow releasing effects. The partially applied position of the paeonol niosome emulsifiable paste has a high medicament utilization rate and substantial medicament reservoir slow releasing effects, and curative effects are improved.

The invention provides a diffractive ring mangiferin in a mango leaf and an application of a mango leaf extract containing the diffractive ring mangiferin in the aspect of antioxidation activity, in particular to an application in preparing a medicine or a cosmetic for preventing or treating symptoms or diseases relevant to an oxygen radical. The symptoms or the diseases relevant to the oxygen radical comprise wrinkles, macula, allergic dermatitis, contact dermatitis or chronic eczema, and the like, and a composition for preventing or treating the symptoms or the diseases relevant to the oxygen radical comprises one or any composition of diffractive ring mangiferin A, diffractive ring mangiferin B or the mango leaf extract with a treating and/or preventing effective dose and an optional pharmaceutical or cosmetic acceptable excipient.

The invention provides a traditional Chinese medicinal composition for treating relapsing allergic dermatitis, wherein fruit of common perilla, peppermint, chrysanthemum and purslane herb are sued as raw medicinal materials and are prepared into orally administrated preparations and externally applied preparations with auxiliary materials according to a conventional process of pharmaceutics. Proved by clinical researches, the medicinal composition has favorable effects of relieving, repairing, allergy resistance, desensitization, skin nourishment and beauty maintain on acute and chronic relapsing allergic dermatitis. Therefore, the medicinal composition can be prepared into various orally administrated preparations and externally applied preparations by adopting the conventional process of the pharmacy of Chinese medicinal herbs; the traditional Chinese medicinal composition can also be used as an active component to produce various skin care products according to the conventional process for producing the skin care products.

The invention discloses a Chinese herbal medicine compound for curing eczema, and the active ingredients for preparing the medicine are composed of the medicinal materials with parts by weight as follows: 1-5 parts of honeysuckle, 2-20 parts of scutellaria baicalensis, 2-20 parts of phellodendron, 5-25 parts of lightyellow sophora root, 2-20 parts of dittany bark, 5-20 parts of pricklyash peel and 2-20 parts of gromwell. The Chinese herbal medicine compound belongs to pure Chinese materia medica preparation, is secure and reliable, is low in price, has no toxic side effects, has short treatment time but obvious treatment effect, eliminates eczema completely, has few recrudescence rate and has excellent effects on acute eczema or chronic eczema, contact dermatitis, and allergic dermatitis, etc.

The present invention relates to an anti-atopic cream comprising: a first component comprising Houttuynia cordata, Acori gramineri Rhizoma, Saposhnikoviae Radix, Astragalus membranaceus Radix, Eriobotryae Folium, Sophorae flavescentis Radix, Saururus chinensis, Phellodendron bark, Centella asiatica, Arisaematis Rhizoma and Aster yomena; and a second component comprising glycerol, a caprylic or capric triglyceride, sunflower seed oil, butylene glycol, butylene glycol dicaprylate or dicaprate, macadamia seed oil, polyglyceryl-3 methylglucose distearate, PEG-4 olivate, meadowfoam seed oil, dimethicone, cetyl ethylhexanoate, oxidized corn oil, cetearyl alcohol, tocopheryl acetate, glyceryl acrylate or acrylic acid copolymer, stearyl glycyrrhetinate, sodium chloride, sodium acrylate or sodium acryloyl dimethyl taurate copolymer, algin, isohexadecane, caprylyl glycol, polysorbate 80, allantoin, caprylhydroxamic acid, propylene glycol, disodium EDTA and ceramide 3 and, in the anti-atopic cream, the first component and the second component are mixed in a weight ratio of between 5:5 and 7:3. According to the present invention, when the anti-atopic cream is applied to a DNCB induced atopic dermatitis mouse, the blood IgE is reduced and at the same time the amount of discharged histamine produced from the mast cells is suppressed, thereby making it possible to provide an anti-atopic cream having a therapeutic effect in atopic dermatitis.